Back to funds
View filing
Bellevue Group AG
hedge fundUpdated 28 days agoManaged by Bellevue Group Ag • Latest filing Q2 2026
Portfolio value
$4.8B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-9.3%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $6.9B |
| Q2 2023 | $7B |
| Q3 2023 | $6.2B |
| Q4 2023 | $6.5B |
| Q1 2024 | $6.6B |
| Q2 2024 | $6.2B |
| Q3 2024 | $6.2B |
| Q4 2024 | $5.2B |
| Q1 2025 | $4.5B |
| Q2 2025 | $4.5B |
| Q3 2025 | $4.8B |
| Q4 2025 | $5.3B |
| Q1 2026 | $4.2B |
| Q2 2026 | $4.8B |
Top holdings
164 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AMGN AMGEN INC | $301.1M | 831.6K | 6.34% | — |
| 2 | A ARGX ARGENX SE | $279.3M | 301.0K | 5.88% | — |
| 3 | V VRTX VERTEX PHARMACEUTICALS INC | $276.9M | 557.4K | 5.83% | — |
| 4 | G GILD GILEAD SCIENCES INC | $264.4M | 2.09M | 5.56% | — |
| 5 | R RVMDW REVOLUTION MEDICINES INC | $195.2M | 1.04M | 4.11% | — |
| 6 | O ORKA ORUKA THERAPEUTICS INC | $157.7M | 1.66M | 3.32% | — |
| 7 | I INSM INSMED INC | $147.3M | 1.38M | 3.10% | — |
| 8 | S SRRK SCHOLAR ROCK HLDG CORP | $134.5M | 2.45M | 2.83% | — |
| 9 | ? N/A NUVALENT INC | $130.1M | 1.05M | 2.74% | — |
| 10 | V VRDN VIRIDIAN THERAPEUTICS INC | $123.4M | 6.72M | 2.60% | — |
| 11 | R RLAY RELAY THERAPEUTICS INC | $115.7M | 6.18M | 2.43% | — |
| 12 | P PCVX VAXCYTE INC | $114.4M | 1.97M | 2.41% | — |
| 13 | I ISRG INTUITIVE SURGICAL INC | $101.3M | 254.8K | 2.13% | — |
| 14 | U UTHR UNITED THERAPEUTICS CORP DEL | $98.8M | 182.3K | 2.08% | — |
| 15 | C CRNX CRINETICS PHARMACEUTICALS IN | $98M | 2.62M | 2.06% | — |
| 16 | R REGN REGENERON PHARMACEUTICALS | $97.9M | 157.0K | 2.06% | — |
| 17 | I IMCR IMMUNOCORE HLDGS PLC | $88.5M | 2.79M | 1.86% | — |
| 18 | B BBIO BRIDGEBIO PHARMA INC | $87.2M | 1.17M | 1.83% | — |
| 19 | A ABT ABBOTT LABORATORIES | $85.9M | 947.1K | 1.81% | — |
| 20 | S SYK STRYKER CORPORATION | $84.5M | 268.5K | 1.78% | — |